Safety of Psychopharmacotherapy in Patients With a Psychosomatic Profile: A Retrospective Study Using the Global Trigger Tool
Open Access
- 25 August 2026
- journal article
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
Abstract
INTRODUCTION. Combined psychopharmacotherapy in patients with comorbid psychiatric and somatic disorders creates a high risk of adverse drug reactions (ADRs). The Global Trigger Tool (GTT) enables active screening and quantitative assessment of ADRs developing under the influence of various factors in routine clinical practice and helps identify directions for optimizing therapeutic strategy. AIM. To evaluate the frequency and structure of ADRs during psychopharmacotherapy in patients with a psychosomatic profile and to identify associations between the use of specific drugs, combined psychopharmacotherapy, and the development of ADRs using the Global Trigger Tool. MATERIALS AND METHODS. A single-center retrospective study was conducted that included 491 medical records of patients hospitalized in a psychosomatic department from January 2024 to March 2025. A list of 27 triggers, adapted for patients receiving psychopharmacotherapy, was used to identify ADRs. Statistical analysis was performed using Fisher exact test. RESULTS. Twenty-five types of ADRs were identified. The most frequently recorded were cardiovascular disorders ( n =211), anticholinergic effects ( n =113), and hematological reactions ( n =89). Concomitant use of 2 or more psychotropic drugs was associated with an increase in the incidence of extrapyramidal symptoms (up to 14.1%, p p p p =0.005); arterial hypotension with valproic acid ( p =0.044); and cardiotoxicity of pramipexole ( p =0.006) and levodopa ( p =0.012). CONCLUSIONS. The GTT is an effective method for retrospective safety audit of psychopharmacotherapy. Combined psychopharmacotherapy is an independent modifiable risk factor. New associations between specific drugs and ADRs were identified that require confirmation and validation in prospective studies.Keywords
This publication has 16 references indexed in Scilit:
- Predictive values of trigger tools for identifying adverse events in hospitalized patients using a medical record review: a systematic reviewInternational Journal for Quality in Health Care, 2025
- Assessment of the occurrence of adverse events through the global trigger tool in a university hospital in ItalyScientific Reports, 2025
- Medications associated with dizziness or hypotension and adverse outcomes: an electronic health record study in older adults with dementiaAge and Ageing, 2025
- Anticholinergic drug exposure is associated with prevalence, worsening and incidence of dysphagia among hospitalized older adultsThe Journal of nutrition, health and aging, 2025
- An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement DisordersCNS Drugs, 2024
- An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designsNeuroscience & Biobehavioral Reviews, 2023
- Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric wardEuropean Geriatric Medicine, 2022
- Serotonin‐Affecting Antidepressant Use in Relation to Platelet ReactivityClinical Pharmacology & Therapeutics, 2022
- Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in GermanyEuropean Journal of Clinical Pharmacology, 2020
- Side effect burden of antipsychotic drugs in real life – Impact of gender and polypharmacyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2018